Herpes Simplex Virus 2 Native Protein

• Reactivity: V-Vi
• Applications: ELISA

Herpes Simplex Virus 2 Native Protein Summary

• Description: Native hHerpes Simplex Virus 2 MS strain, cultured in BSC-1, a cell line derived from African Green monkey kidney.
  
  Source:Virus
• Preparation Method: Herpes simplex virus 2 antigen is collected from both the cell and supernatant phases of tissue culture. The antigen is harvested by disrupting optimally infected monolayers in the tissue culture medium. Cellular debris is removed by centrifugation. The antigen preparation is inactivated using gamma radiation, which primarily damages viral genetic material.
• Protein/Peptide Type: Native Protein

Applications/Dilutions

• Dilutions:
  • ELISA
• Application Notes: The product should be sonicated immediately before use to ensure the preparation is uniform. The product may be used in a variety of immunoassay formats or may be further purified to meet the requirements of a particular assay format.

Packaging, Storage & Formulations

• Storage: Store at -70C. Avoid freeze-thaw cycles.
• Buffer: Tissue culture medium
• Preservative: No Preservative

Alternate Names for Herpes Simplex Virus 2 Native Protein

• Herpes Simplex Virus Type 2

Background

Herpes simplex type 2 (HSV2) belongs to a family that includes HSV1, Epstein-Barr virus (EBV) and Varicella zoster (chicken pox) virus. HSV1 and HSV2 are extremely difficult to distinguish from each other. These viruses have a DNA genome, an icosahedral protein coat and are encased in a lipid membrane derived from the nuclear membrane of the last host. These viruses are capable of entering a latent phase where the host shows no visible sign of infection and levels of infectious agent become very low. During the latent phase the viral DNA is integrated into the genome of the host cell.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Peptides and proteins are guaranteed for 3 months from date of receipt.